Merck
MRK
#55
Rank
HK$2.151 T
Marketcap
HK$861.51
Share price
1.78%
Change (1 day)
13.94%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): HK$59.18

According to Merck's latest financial reports the company's current EPS (TTM) is HK$59.33. In 2024 the company made an earnings per share (EPS) of HK$52.81 an increase over its 2023 EPS that were of HK$1.20.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$59.1812.07%
2024HK$52.814308.46%
2023HK$1.20-97.32%
2022HK$44.7710.92%
2021HK$40.3684.68%
2020HK$21.85-27.2%
2019HK$30.0263.44%
2018HK$18.37151.11%
2017HK$7.31-54.58%
2016HK$16.1030.21%
2015HK$12.37-61.99%
2014HK$32.53180.51%
2013HK$11.60-31.82%
2012HK$17.016.62%
2011HK$15.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.50-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$13.44-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.95 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$160.30 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.80 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.95-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$23.20-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$28.09-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.92-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel